POTE ankyrin domain family member K, pseudogene (POTEP)

POTE ankyrin domain family member K, pseudogene (POTEKP) is classified as a pseudogene, meaning it is a non-functional remnant of a gene that does not encode a functional protein product in humans. While it shares sequence similarity with actin and POTE family members and is predicted to enable protein kinase binding and act as a structural constituent of the postsynaptic actin cytoskeleton, these functions are not experimentally confirmed and are inferred computationally. There is no evidence to support a role for POTEKP as a therapeutic target, nor are there known drug interactions, disease associations, or biomarker applications. Some database entries refer to it as a "putative protein," but all curated sources indicate it is a pseudogene and not an active receptor, enzyme, or other classical therapeutic target[1][2][5][6][8]. Key points: - POTEKP is not considered a functional protein-coding gene; it is a pseudogene and not a validated drug or diagnostic target. - No clear therapeutic role, mechanism, or disease association has been reported. - Its predicted functions are based on sequence homology and have not been experimentally validated. - The term "pseudogene" itself flags it as not an active or targetable entity in drug discovery or clinical settings[1][5][6][8].

Other names

Putative beta-actin-like protein 3ACTBL3FKSG30POTE2deltaKappa-actinPOTEKactin beta-like 3